Effect of eliminating intermittent white blood cells on immunology and cellular factors of systemic lupus erythematosus

作者: Lin-Fang Guo , Ruo-Hua Chen , Jin-Jin Jiang , Feng Fang

DOI:

关键词:

摘要: Background: SLE is treated currently by multiple immunosuppression, but side-effects are obvious after long time administration. This study was to observe changes in T, B cells, NK cells and IL12 patients with systemic lupus erythematosus (SLE) before treatment of eliminating intermittent white blood probe the mechanism this treatment. Methods: In 23 SLE, 5 were male 18 female, an average age 15.78±5.40 years. These accepted cells. The expressions CD19 + , CD3 CD4 CD8 /CD8 CD(15+56) tested flow cytometry amounts immunoglobulins, IgM, IgG, IgA periphery measured separately immunoradiometric analysis level detected ELISA. Twenty volunteers served as controls. Results: expression increased markedly Statistical significance noted control group patient (P<0.01 or P<0.001). IgM IgG seen between activated (P<0.05) 0.001) respectively. decreased P<0.05) (P<0.001) ratio (P<0.01). more remarkably than (P<0.05). suggested that

参考文章(11)
Kjell Eneslãtt, Solbritt Rantapãã-Dahlqvist, Agneta Uddhammar, Karl-gõsta Sundqvist, The Regulation of FasL Expression—A Distinguishing Feature Between Monocytes and T Lymphocytes/NK Cells with Possible Implications for SLE Journal of Clinical Immunology. ,vol. 21, pp. 183- 192 ,(2001) , 10.1023/A:1011035115342
R Chizzonite, A G Wolitzky, F J Podlaski, A S Stern, P Nunes, M K Gately, P M Quinn, T Truitt, IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. Journal of Immunology. ,vol. 147, pp. 1548- 1556 ,(1991)
Ewa Robak, Jerzy Z. Błoński, Jacek Bartkowiak, Hanna Niewiadomska, Anna Sysa-Jędrzejowska, Tadeusz Robak, Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus. Mediators of Inflammation. ,vol. 8, pp. 305- 312 ,(1999) , 10.1080/09629359990315
Do-June Min, Mi-La Cho, Chul-Soo Ch, Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus. Scandinavian Journal of Rheumatology. ,vol. 30, pp. 159- 163 ,(2001) , 10.1080/030097401300162932
Clemens Scheinecker, Bettina Zw�lfer, Markus K�ller, Georg M�nner, Josef S. Smolen, Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis & Rheumatism. ,vol. 44, pp. 856- 865 ,(2001) , 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A
Sylvie Trembleau, Giuseppe Penna, Emanuele Bosi, Anna Mortara, Maurice K Gately, Luciano Adorini, None, Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. Journal of Experimental Medicine. ,vol. 181, pp. 817- 821 ,(1995) , 10.1084/JEM.181.2.817
J P Leonard, K E Waldburger, S J Goldman, Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine. ,vol. 181, pp. 381- 386 ,(1995) , 10.1084/JEM.181.1.381
J Avery, T Lehner, T Jones, The role of a human antigen specific T8+ cell subset in antigen presentation, helper function and contrasuppression. Clinical and Experimental Immunology. ,vol. 61, pp. 203- ,(1985)